2012
DOI: 10.1016/j.foodchem.2011.11.029
|View full text |Cite
|
Sign up to set email alerts
|

Simultaneous separate and group determination of tylosin and tilmicosin in foodstuffs using single antibody-based immunoassay

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
10
0
3

Year Published

2013
2013
2024
2024

Publication Types

Select...
5
1

Relationship

1
5

Authors

Journals

citations
Cited by 29 publications
(13 citation statements)
references
References 19 publications
0
10
0
3
Order By: Relevance
“…Besides, the equivalence and/or similarity in cross-reactivity of the 14-membered macrolides ERY, CLA, and ROX allowed their quantification using one marker analyte. The related approach was described previously for the tylosin/tilmicosin model [24]. Note.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Besides, the equivalence and/or similarity in cross-reactivity of the 14-membered macrolides ERY, CLA, and ROX allowed their quantification using one marker analyte. The related approach was described previously for the tylosin/tilmicosin model [24]. Note.…”
Section: Discussionmentioning
confidence: 99%
“…Pretreatment of honey was carried out according to the procedure described in our previous work concerning 16-membered macrolides [24]. Briefly, honey samples melted at 50°C were taken in a 1-cm 3 syringe without a needle and then added to PBS-T and dissolved.…”
Section: Sample Preparationmentioning
confidence: 99%
“…Nos Estados Unidos, o uso da tilosina é aprovado tanto para fins terapêuticos como promotor de crescimento em animais. Em geral, no mundo inteiro as drogas mais utilizadas como promotores de crescimento incluem os macrolídeos (tilosina e espiramicina) dentre outras classes de antimicrobianos [16,17] . A Organização Mundial da Saúde (OMS) classificou os antibióticos macrolídeos como uma das três principais classes para o desenvolvimento de estratégias de gestão de risco a fim de preservar sua eficácia na medicina humana, já que a resistência pode emergir em patógenos zoonóticos como Campylobacter spp.…”
Section: Introductionunclassified
“…-Desenvolvimento de micro-organismos resitentes a antimicrobianos usados na terapia humana [19,16] .…”
Section: Introductionunclassified
See 1 more Smart Citation